Pharmacovigilance Documents

BC-CfE Pharmacovigilance 2016 Annual Report

SAFETY UPDATE: Antiretroviral drug interactions with non-prescription medications

SAFETY UPDATE: Nevirapine 400 mg XR (Viramune XR™) tablet remnants in feces

SAFETY ALERT: DARUNAVIR (PREZISTA TM)

SAFETY ALERT: RITONAVIR AND INTRA-ARTICULAR TRIMCINOLONE ACETONIDE INJECTION

SAFETY WARNING: ABACAVIR USE IN HLA-B*5701 POSITIVE PATIENTS AND UNTESTED PATIENTS

Scroll to Top

During the Canada Post strike, the following measures have been undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office.  (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During this time, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service.

Start typing and press enter to search